JEFFREY M SANWICK MD NPI 1952339723

NPI Details

Jeffrey M Sanwick, MD is a specialist in Prescott, AZ. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. Jeffrey M Sanwick, MD NPI is 1952339723. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

811 AINSWORTH DR
SUITE 101
PRESCOTT, AZ
ZIP 86301-687
Phone: (928) 771-5282
Fax: (928) 771-5283

The NPI 1952339723 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Detection test by nucleic acid for organism, quantification (HCPCS:87799)
• Detection test by nucleic acid for strep (streptococcus, group a), quantification (HCPCS:87652)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), quantification (HCPCS:87592)
• Detection test by nucleic acid for chlamydia trachomatis, quantification (HCPCS:87492)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Biopsy of prostate gland (HCPCS:55700)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Crushing of stone of ureter using an endoscope (HCPCS:52353)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Insertion of temporary bladder tube (HCPCS:51701)
• Detection test for gardnerella vaginalis (bacteria), direct probe technique (HCPCS:87510)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)

The enumeration date for this NPI number is 6/29/2006 and was last updated on 7/26/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.